Histopathological changes following photodynamic therapy in human eyes.
Schmidt-Erfurth
Ursula
U
Department of Ophthalmology, University Eye Hospital Luebeck, Germany. uschmidterfurth@ophtha.mu-luebeck.de
Laqua
Horst
H
Schlötzer-Schrehard
Ursula
U
Viestenz
Arne
A
Naumann
Gottfried O H
GO
D000368:Aged; D000369:Aged, 80 and over; D002829:Choroid / Q000473:pathology* / Q000648:ultrastructure; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000473:pathology; D004730:Endothelium, Vascular / Q000473:pathology / Q000648:ultrastructure; D015353:Eye Enucleation; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green; D008268:Macular Degeneration / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000601:surgery; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D010857:Pigment Epithelium of Eye / Q000473:pathology* / Q000648:ultrastructure; D011166:Porphyrins / Q000627:therapeutic use*; D012160:Retina / Q000473:pathology* / Q000648:ultrastructure; D012171:Retinal Vessels / Q000473:pathology / Q000648:ultrastructure; D014604:Uveal Neoplasms / Q000601:surgery; D000077362:Verteporfin
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; D007208:Indocyanine Green